vs
PDF SOLUTIONS INC（PDFS）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
PDF SOLUTIONS INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.8倍（$62.4M vs $35.5M），PDF SOLUTIONS INC净利率更高（-0.1% vs -304.2%，领先304.2%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 24.6%），PDF SOLUTIONS INC自由现金流更多（$7.5M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 22.9%）
PDF Solutions Inc是一家总部位于美国加利福尼亚州圣克拉拉的跨国企业，主营软件业务与工程技术服务，目前在纳斯达克交易所挂牌上市，股票代码为PDFS。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
PDFS vs RXRX — 直观对比
营收规模更大
PDFS
是对方的1.8倍
$35.5M
营收增速更快
RXRX
高出657.1%
24.6%
净利率更高
PDFS
高出304.2%
-304.2%
自由现金流更多
PDFS
多$54.9M
$-47.3M
两年增速更快
RXRX
近两年复合增速
22.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.4M | $35.5M |
| 净利润 | $-48.0K | $-108.1M |
| 毛利率 | 72.9% | 59.8% |
| 营业利润率 | 5.5% | -304.8% |
| 净利率 | -0.1% | -304.2% |
| 营收同比 | 24.6% | 681.7% |
| 净利润同比 | -108.9% | 39.6% |
| 每股收益（稀释后） | $0.00 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PDFSRXRX
| Q4 25 | $62.4M | $35.5M | ||
| Q3 25 | $57.1M | $5.2M | ||
| Q2 25 | $51.7M | $19.2M | ||
| Q1 25 | $47.8M | $14.7M | ||
| Q4 24 | $50.1M | $4.5M | ||
| Q3 24 | $46.4M | $26.1M | ||
| Q2 24 | $41.7M | $14.4M | ||
| Q1 24 | $41.3M | $13.8M |
净利润PDFSRXRX
| Q4 25 | $-48.0K | $-108.1M | ||
| Q3 25 | $1.3M | $-162.3M | ||
| Q2 25 | $1.1M | $-171.9M | ||
| Q1 25 | $-3.0M | $-202.5M | ||
| Q4 24 | $539.0K | $-178.9M | ||
| Q3 24 | $2.2M | $-95.8M | ||
| Q2 24 | $1.7M | $-97.5M | ||
| Q1 24 | $-393.0K | $-91.4M |
毛利率PDFSRXRX
| Q4 25 | 72.9% | 59.8% | ||
| Q3 25 | 72.3% | -183.8% | ||
| Q2 25 | 71.2% | -4.9% | ||
| Q1 25 | 72.9% | -48.0% | ||
| Q4 24 | 68.3% | -181.4% | ||
| Q3 24 | 73.1% | 53.7% | ||
| Q2 24 | 70.6% | 36.2% | ||
| Q1 24 | 67.3% | 19.1% |
营业利润率PDFSRXRX
| Q4 25 | 5.5% | -304.8% | ||
| Q3 25 | 8.5% | -3327.6% | ||
| Q2 25 | 2.2% | -916.8% | ||
| Q1 25 | -7.4% | -1297.9% | ||
| Q4 24 | 1.0% | -4042.4% | ||
| Q3 24 | 4.6% | -377.1% | ||
| Q2 24 | 0.6% | -697.4% | ||
| Q1 24 | -4.7% | -698.4% |
净利率PDFSRXRX
| Q4 25 | -0.1% | -304.2% | ||
| Q3 25 | 2.3% | -3135.3% | ||
| Q2 25 | 2.2% | -894.2% | ||
| Q1 25 | -6.3% | -1373.3% | ||
| Q4 24 | 1.1% | -3935.5% | ||
| Q3 24 | 4.8% | -367.5% | ||
| Q2 24 | 4.1% | -676.6% | ||
| Q1 24 | -1.0% | -662.4% |
每股收益（稀释后）PDFSRXRX
| Q4 25 | $0.00 | $-0.17 | ||
| Q3 25 | $0.03 | $-0.36 | ||
| Q2 25 | $0.03 | $-0.41 | ||
| Q1 25 | $-0.08 | $-0.50 | ||
| Q4 24 | $0.01 | $-0.56 | ||
| Q3 24 | $0.06 | $-0.34 | ||
| Q2 24 | $0.04 | $-0.40 | ||
| Q1 24 | $-0.01 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.2M | $743.3M |
| 总债务越低越好 | $67.0M | $9.6M |
| 股东权益账面价值 | $271.0M | $1.1B |
| 总资产 | $418.7M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.25× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资PDFSRXRX
| Q4 25 | $42.2M | $743.3M | ||
| Q3 25 | $35.9M | $659.8M | ||
| Q2 25 | $40.4M | $525.1M | ||
| Q1 25 | $54.1M | $500.5M | ||
| Q4 24 | $114.9M | $594.4M | ||
| Q3 24 | $120.2M | $427.6M | ||
| Q2 24 | $117.9M | $474.3M | ||
| Q1 24 | $122.9M | $296.3M |
总债务PDFSRXRX
| Q4 25 | $67.0M | $9.6M | ||
| Q3 25 | $67.6M | $11.9M | ||
| Q2 25 | $68.1M | $14.2M | ||
| Q1 25 | $68.7M | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益PDFSRXRX
| Q4 25 | $271.0M | $1.1B | ||
| Q3 25 | $264.4M | $1.0B | ||
| Q2 25 | $257.5M | $919.1M | ||
| Q1 25 | $249.0M | $933.9M | ||
| Q4 24 | $246.0M | $1.0B | ||
| Q3 24 | $240.5M | $524.6M | ||
| Q2 24 | $232.2M | $584.4M | ||
| Q1 24 | $225.4M | $401.2M |
总资产PDFSRXRX
| Q4 25 | $418.7M | $1.5B | ||
| Q3 25 | $406.4M | $1.4B | ||
| Q2 25 | $391.1M | $1.3B | ||
| Q1 25 | $390.0M | $1.3B | ||
| Q4 24 | $315.3M | $1.4B | ||
| Q3 24 | $307.4M | $726.5M | ||
| Q2 24 | $298.0M | $775.9M | ||
| Q1 24 | $286.8M | $557.8M |
负债/权益比PDFSRXRX
| Q4 25 | 0.25× | 0.01× | ||
| Q3 25 | 0.26× | 0.01× | ||
| Q2 25 | 0.26× | 0.02× | ||
| Q1 25 | 0.28× | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.3M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $7.5M | $-47.3M |
| 自由现金流率自由现金流/营收 | 12.1% | -133.1% |
| 资本支出强度资本支出/营收 | 15.7% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.6M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流PDFSRXRX
| Q4 25 | $17.3M | $-46.1M | ||
| Q3 25 | $3.3M | $-117.4M | ||
| Q2 25 | $-5.2M | $-76.4M | ||
| Q1 25 | $8.6M | $-132.0M | ||
| Q4 24 | $1.6M | $-115.4M | ||
| Q3 24 | $9.3M | $-59.2M | ||
| Q2 24 | $684.0K | $-82.2M | ||
| Q1 24 | $-1.9M | $-102.3M |
自由现金流PDFSRXRX
| Q4 25 | $7.5M | $-47.3M | ||
| Q3 25 | $-2.9M | $-117.6M | ||
| Q2 25 | $-13.8M | $-79.6M | ||
| Q1 25 | $535.0K | $-133.8M | ||
| Q4 24 | $-4.0M | $-116.7M | ||
| Q3 24 | $5.1M | $-63.8M | ||
| Q2 24 | $-4.6M | $-83.4M | ||
| Q1 24 | $-3.9M | $-109.0M |
自由现金流率PDFSRXRX
| Q4 25 | 12.1% | -133.1% | ||
| Q3 25 | -5.1% | -2272.5% | ||
| Q2 25 | -26.6% | -413.9% | ||
| Q1 25 | 1.1% | -907.4% | ||
| Q4 24 | -8.0% | -2567.7% | ||
| Q3 24 | 11.0% | -244.6% | ||
| Q2 24 | -11.1% | -578.5% | ||
| Q1 24 | -9.4% | -789.9% |
资本支出强度PDFSRXRX
| Q4 25 | 15.7% | 3.5% | ||
| Q3 25 | 10.8% | 4.7% | ||
| Q2 25 | 16.5% | 16.4% | ||
| Q1 25 | 17.0% | 12.4% | ||
| Q4 24 | 11.3% | 28.6% | ||
| Q3 24 | 9.0% | 17.5% | ||
| Q2 24 | 12.8% | 8.2% | ||
| Q1 24 | 4.9% | 48.2% |
现金转化率PDFSRXRX
| Q4 25 | — | — | ||
| Q3 25 | 2.54× | — | ||
| Q2 25 | -4.55× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.98× | — | ||
| Q3 24 | 4.20× | — | ||
| Q2 24 | 0.40× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PDFS
| Volumebased | $38.0M | 61% |
| Other | $24.4M | 39% |
RXRX
暂无分部数据
